~~<i id='26F55B9C3D'><strike id='26F55B9C3D'><tt id='26F55B9C3D'><pre id='26F55B9C3D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

comprehensive

author：leisure time 2025-09-03 14:41:47 - browse：41773

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Hospital at home shows how to bring innovation to health care

focus

entertainment

explore

focus

hotspot

leisure time

NeurocrineBiosciencesdecidedtojoinPhRMA.AdobeWASHINGTON—NeurocrineBiosciences,abiotechcompanybasedin

WSS

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

PBM reform efforts get punted in Congress

Meadows told special counsel he could not recall Trump ever declassifying Mar

Why palliative psychiatry is worth discussing

Alabama hospital puts IVF treatments on hold

Health officials lay out plans to cope with respiratory virus season

hotspot

comprehensive

focus

Heart attack and stroke risk calculators need revising

New documents shed light on MD Anderson Cancer Institute feud

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Roche's accidental data boosts hopes for anti

Dobbs anniversary: the lost opportunity of abortion as health care

The Harvard botanist who searched for psychedelics in the Amazon

Bright Health sells Medicare Advantage business to Molina

FDA advisory panel to debate high blood pressure devices

Medicare proposal to cover medical devices draws a mixed reaction

The Harvard botanist who searched for psychedelics in the Amazon

entertainment

Former Pear Therapeutics executives start new VC firm

How the drug

Former Pear Therapeutics executives start new VC firm

Kellogg’s is going to war over Mexico’s nutrition label rules

6 phony surgeries that take placebo to the extreme

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

explore

focus

hotspot

leisure time